Liebowitz, M R

Reversible MAO inhibitors in social phobia bulimia, and other disorders. [electronic resource] - Clinical neuropharmacology 1992 - 434A-435A p. digital

Publication Type: Journal Article

0362-5664

10.1097/00002826-199201001-00227 doi


Bulimia--drug therapy
Humans
Monoamine Oxidase Inhibitors--adverse effects
Phobic Disorders--drug therapy